Combinatorial effect of TIMP-1 and α 1AT gene polymorphisms on development of chronic obstructive pulmonary disease

Clinical Biochemistry

Volumn 44, Issue 13, 2011, Pages 1067-1073

  Kumar, Manish ^a,c   Bhadoria, D P ^b   Dutta, Koushik ^b   Singh, Seema ^a,c   Gupta, Jyotsana ^d   Kumar, Ram ^a   Chhillar, Anil K ^e   Yadav, Vibha ^f   Singh, Bharat ^a   Sharma, G L ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

^c UNIVERSITY OF PUNE   (India)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e MAHARSHI DAYANAND UNIVERSITY   (India)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Alpha 1 antitrypsin; Chronic obstructive pulmonary disease; Gene interaction; Tissue inhibitor of metalloproteinase 1

Indexed keywords

ALPHA 1 ANTITRYPSIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ALPHA 1-ANTITRYPSIN; CASE-CONTROL STUDIES; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 80051702878     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.06.986     Document Type: Article

References (40)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J.L. Global burden of disease and risk factors 2006, The World Bank, Washington DC.
2. Lopez A.D., Shibuya K., Rao C., Mathers C.D., Hansell A.L., Held L.S., et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Resp J 2006, 27:397-412.
3. Churg A., Wright J.L. Proteases and emphysema. Curr Opin Pulm Med 2005, 11:152-159.
4. Mahadeva R., Lomas D.A. Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 1998, 53:501-505.
5. Crystal R.G., Brantly M.L., Hubbard R.C., Curiel D.T., States D.J., Holmes M.D. The alpha-1-antitrypsin gene and its mutations: clinical consequences and strategies for therapy. Chest 1989, 95:196-208.
6. Fabbretti G., Sergi C., Consales G., Faa G., Brisigotti M., Romeo G., et al. Genetic variants of alpha-1-antitrypsin (AAT). Liver 1992, 12:296-301.
7. Kueppers F., Black L.F. Alpha 1-antitrypsin and its deficiency. Am Rev Respir Dis 1974, 110:176-194.
8. Poller W., Meisen C., Olek K. DNA polymorphisms of alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur J Clin Invest 1990, 20:1-7.
9. Dahl M., Hersh C.P., Ly N.P., Berkey C.S., Silverman E.K., Nordestgaard B.G. The protease inhibitor PIS allele and COPD: a meta-analysis. Eur Respir J 2005, 26(1):67-76.
10. Gupta J., Bhadoria D.P., Lal M.K., Kukreti R., Chattopadhaya D., Gupta V.K., et al. Association of the PIM3 allele of the alpha-1-antitrypsin gene with chronic obstructive pulmonary disease. Clin Biochem 2005, 38:489-491.
11. Gupta J, Chattopadhaya D, Bhadoria DP, Qadar Pasha MA, Gupta VK, Kumar M, et al. T lymphocyte subset profile and serum alpha-1-antitrypsin in pathogenesis of chronic obstructive pulmonary disease. Clin Exp Immunol 2007;149(3):463-9.
12. Pons A.R., Sauleda J., Noguera A., Pons J., Barceló B., Fuster A., et al. Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease. Eur Resp J 2005, 26:60-66.
13. Lose F., Thompson P.J., Duffy D., Stewart G.A., Kedda M.A. A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women. Thorax 2005, 60:623-628.
14. Qiu Y., Zhu J., Bandi V., Atmar R.L., Hattotuwa K., Guntupalli K.K., et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Resp Crit Care Med 2003, 168:968-975.
15. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
16. Eriksson S. Studies in alpha-1-antitrypsin deficiency. Acta Med Scand 1965, 177:1-85.
17. Cataldo D., Munaut C., Noel A., Frankenne F., Bartsch P., Foidart J.M., et al. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2000, 123:259-267.
18. Beeh K.M., Beier J., Kornmann O., Buhl R. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med 2003, 97:634-639.
19. Cataldo D.D., Bettiol J., Noël A., Bartsch P., Foidart J.M., Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002, 122:1553-1559.
20. Higashimoto Y., Yamagata Y., Iwata T., Okada M., Ishiguchi T., Sato H., et al. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients. Eur Res J 2005, 25:885-890.
21. Louhelainen N., Stark H., Mazur W., Rytila P., Djukanovic R., Kinnula V.L. Elevation of sputum matrix metalloproteinase-9 persists up to 6months after smoking cessation: a research study. BMC Pulm Med 2010, 10:13.
22. Jansson A.E., Andersson B., Bake B., Boijsen M., Enanden I., Rosengren A., et al. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Resp Med 2001, 95:363-373.
23. Corrigan CJ, Haczku A, Gemou-Engesaeth V, Doi S, Kikuchi Y, Takatsu K, et al. CD4T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Resp Dis 1993;147:540-7.
24. Alexander A.G., Barkans J., Moqbel R., Barnes N.C., Kay A.B., Corrigan C.J. Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. Thorax 1994, 49:1231-1233.
25. Bafadhel M., Saha S., Siva R., McCormick M., Monteiro W., Rugman P., et al. Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD. Respiration 2009, 78(3):256-262.
26. Hacievliyagil S.S., Gunen H., Mutlu L.C., Karabulut A.B., Temel I. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med 2006, 100:846-854.
27. Mio T., Romberger D.J., Thompson A.B., Robbins R.A., Heires A., Rennard S.I. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 1997, 155:1770-1776.
28. Kuschner W.G., D'Alessandro A., Wong H., Blanc P.D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996, 1989-1994.
29. Keatings V.M., Collins P.D., Scott D.M., Barnes P.J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996, 153:530-534.
30. Dubar V., Gosset P., Aerts C., Voisin C., Wallaert B., Tonnel A.B. In vitro acute effects of tobacco smoke on tumor necrosis factor alpha and interleukin-6 production by alveolar macrophages. Exp Lung Res 1993, 19:345-359.
31. Vibhuti A., Arif E., Mishra A., Deepak D., Singh B., Rahman I., et al. CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD. Clin Chem Act 2010, 411:474-480.
32. Thakur H., Gupta L., Sobti R.C., Janmeja A.K., Seth A., Singh S.K. Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population. Mol Biol Rep 2011, 38:1733-1739.
33. Mehrotra S., Sharma A., Kumar S., Kar P., Sardana S., Sharma J.K. Polymorphism of glutathione S-transferase M1 and T1 gene loci in COPD. Int J Immunogenet 2010, 37:263-267.
34. Sobti R.C., Thakur H., Gupta L., Janmeja A.K., Seth A., Singh S.K. Polymorphisms in the HPC/ELAC-2 and alpha 1-antitrypsin genes that correlate with human diseases in a North Indian population. Mol Biol Rep 2010, 10.1007/s11033-010-9984-6.
35. Kwok J.S., Lawton J.W., Yew W.W., Chau C.H., Lee J., Wong P.C. Protease inhibitor phenotypes and serum alpha-1-antitrypsin levels in patients with COPD: a study from Hong Kong. Respirology 2004, 9:265-270.
36. Kim C.H., Yim J.J., Yoo C.G., Lee C.T., Kim Y.W., Han S.K., et al. α1-antitrypsin genotypes in Korean patients with chronic obstructive pulmonary disease. Respirology 2005, 10:223-228.
37. Denden S., Khelil A.H., Knani J., Lakhdar R., Perrin P., Lefranc G., et al. Alpha-1 antitrypsin gene polymorphism in chronic obstructive pulmonary disease (COPD). Genet Mol Bio 2010, 33(1):23-26.
38. Liang C.L., Wang H.S., Hung K.S., Hsi E., Sun A., Kuo Y.H., et al. Evaluation of MMP3 and TIMP1 as candidate genes for high myopia in young Taiwanese men. Am J Ophthalmol 2006, 142(3):518-520.
39. Hinterseher I., Krex D., Kuhlisch E., Schmidt K.G., Pilarsky C., Schneiders W., et al. Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm. World J Surg 2007, 31:2248-2254.
40. Indelicato M., Chiarenza V., Libra M., Malaponte G., Bevelacqua V., Marchini M., et al. Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients. J Clin Lab Anal 2006, 20(5):173-176.